Interpretable classification of Alzheimer's disease pathologies with a convolutional neural network pipeline.
Ziqi TangKangway V ChuangCharles DeCarliLee-Way JinLaurel A BeckettMichael J KeiserBrittany N DuggerPublished in: Nature communications (2019)
Neuropathologists assess vast brain areas to identify diverse and subtly-differentiated morphologies. Standard semi-quantitative scoring approaches, however, are coarse-grained and lack precise neuroanatomic localization. We report a proof-of-concept deep learning pipeline that identifies specific neuropathologies-amyloid plaques and cerebral amyloid angiopathy-in immunohistochemically-stained archival slides. Using automated segmentation of stained objects and a cloud-based interface, we annotate > 70,000 plaque candidates from 43 whole slide images (WSIs) to train and evaluate convolutional neural networks. Networks achieve strong plaque classification on a 10-WSI hold-out set (0.993 and 0.743 areas under the receiver operating characteristic and precision recall curve, respectively). Prediction confidence maps visualize morphology distributions at high resolution. Resulting network-derived amyloid beta (Aβ)-burden scores correlate well with established semi-quantitative scores on a 30-WSI blinded hold-out. Finally, saliency mapping demonstrates that networks learn patterns agreeing with accepted pathologic features. This scalable means to augment a neuropathologist's ability suggests a route to neuropathologic deep phenotyping.
Keyphrases
- deep learning
- convolutional neural network
- high resolution
- artificial intelligence
- machine learning
- molecular dynamics
- coronary artery disease
- high speed
- mass spectrometry
- subarachnoid hemorrhage
- high throughput
- cerebral ischemia
- neoadjuvant chemotherapy
- resting state
- cognitive decline
- squamous cell carcinoma
- tandem mass spectrometry
- randomized controlled trial
- brain injury
- high density
- lymph node
- dna methylation
- gene expression
- functional connectivity